Rapid detection of antigen refers to the application of new coronavirus nucleocapsid protein-specific antibodies in the direct detection of pathogens in a sample, the result can be used as direct evidence of early identification of infection the pathogen or not, detecting a rapid (15min), convenient operation of the New coronavirus detection method. Applicable scenarios: Weak nucleic acid detection capabilities, insufficient detection capabilities, and places where urgent results are needed. It has been widely used in Europe, America, Asia, Africa and other regions, and together with nucleic acid testing has become an important detection method for the prevention and control of the COVID-19 epidemic.(Not Available in the U.S)
1. In the current epidemic situation, virus sample collection is an important part of virus detection. 2. The single-use virus sampling tube can collect, transport, Inactivate and store virus samples from specific parts of the human body.(Not Available in the U.S)
BNP32 / BNP48 System is a fully-automated clinical nucleic acid extraction system that brings you walk-away automation, designed to minimize user intervention and extraction-to-extraction variability. In addition to providing quality purified eluates, the BNP32 / BNP48 System offers onboard primary-sample handling and mixed-batch sampling for up to 32 or 48 samples per run.
Automatic nucleic acid extraction and purification system for the extraction of DNA or RNA from a variety of materials,such as whole blood, tissue, throat swab, etc., without centrifugation or filtration operation.
Real- time PCR is used for sensitive, specific detection and quantification of nucleic acid targets. We have developed powerful assay design algorithms, optimized qPCR regent, intuitive data analysis software, and flexible instrumentation to help harness the power of qPCR across a rich and diverse set of applications. Explore our robust solutions for your qPCR-based research.
The magnetic beads and buffer system with unique separation effect can be used to extract high-purity viral DNA/RNA from samples quickly, highly sensitively and efficiently. The extracted and purified nucleic acid can be used in various common downstream experiments such as restriction digestion, reverse transcription, PCR, RT-PCR, Southernblot, etc.Scope of application: rapid extraction of viral DNA or RNA from plasma, serum, urine, ascites, cell culture fluid, supernatant, and cell free body fluid.
Founded in 1999, having over 5000 employees , BIOBASE Group is a new high-tech enterprise focusing on development, production and management of scientific equipment, In Vitro Diagnosis (IVD) instrument and reagent.
BIOBASE Group is specialized in products of 8 areas including medical diagnosis, biosafety protection, disinfection and sterilization, water purification system, infant care products, cold chain products, software products, clean room project.
BIOBASE Group have completed the construction of BIOBASE first industrial park in Zhangqiu, covering an area of 80,000 square meters, second industrial park in Tangye new district, covering an area of 160,000 square meters, and USA incubator in Silicon valley, covering an area of 2000 square meters.
24hours online to ensure quick response to customers' inquiry. Broken spare parts will be sent for free due to quality problems.
There are more than 100 employees in R&D team, more than 200 employees in sales team and about 11 employees in after-sales team.
We has certificates including ISO9001, ISO13485, ISO 14001, SGS, CE, NSF, EN, FDA, etc.
We now have long-term business partners in more than 130 countries.
BIOBASE Group always adheres to the mission of “service for health for the future” and promotes company’s culture vigorously.
On the afternoon of November 16th, the 2023 MEDICA successfully concluded. At this exhibition, BIOBASE once again showcased its latest technological achievements to the industry, providing a huge boost to further developing the local market. Read More